SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage
- PMID: 29946510
- PMCID: PMC6008284
- DOI: 10.1016/j.nicl.2018.05.031
SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage
Abstract
SPG11 mutations are the major cause of autosomal recessive Hereditary Spastic Paraplegia. The disease has a wide phenotypic variability indicating many regions of the nervous system besides the corticospinal tract are affected. Despite this, anatomical and phenotypic characterization is restricted. In the present study, we investigate the anatomical abnormalities related to SPG11 mutations and how they relate to clinical and cognitive measures. Moreover, we aim to depict how the disease course influences the regions affected, unraveling different susceptibility of specific neuronal populations. We performed clinical and paraclinical studies encompassing neuropsychological, neuroimaging, and neurophysiological tools in a cohort of twenty-five patients and age matched controls. We assessed cortical thickness (FreeSurfer software), deep grey matter volumes (T1-MultiAtlas tool), white matter microstructural damage (DTI-MultiAtlas) and spinal cord morphometry (Spineseg software) on a 3 T MRI scan. Mean age and disease duration were 29 and 13.2 years respectively. Sixty-four percent of the patients were wheelchair bound while 84% were demented. We were able to unfold a diffuse pattern of white matter integrity loss as well as basal ganglia and spinal cord atrophy. Such findings contrasted with a restricted pattern of cortical thinning (motor, limbic and parietal cortices). Electromyography revealed motor neuronopathy affecting 96% of the probands. Correlations with disease duration pointed towards a progressive degeneration of multiple grey matter structures and spinal cord, but not of the white matter. SPG11-related hereditary spastic paraplegia is characterized by selective neuronal vulnerability, in which a precocious and widespread white matter involvement is later followed by a restricted but clearly progressive grey matter degeneration.
Keywords: ACE-R, Addenbrooke's Cognitive Examination Revised; ALS, amyotrophic lateral sclerosis; CA, cord area; CE, cord eccentricity; CMAP, compound muscle action potential; CST, corticospinal tract; Complicated hereditary spastic paraplegia; DTI, diffusion tensor imaging; FA, fractional anisotropy; GM, grey matter; Grey matter; HSP, hereditary spastic paraplegia; LH, left hemisphere; MD, mean diffusivity; MOCA, Montreal cognitive assessment; Motor neuron disorder; NPI, neuropsychiatric inventory; PNP, sensory-motor polyneuropathy; PNS, peripheral nervous system; RH, right hemisphere; ROI, region of interest; SC, spinal cord; SNAP, sensory nerve action potential; SPG11; SPRS, Spastic Paraplegia Rating Scale; STS, cortex adjacent to the superior temporal sulcus; Spinal cord; Thinning of the corpus callosum; WES, whole exome sequencing; WM, white matter; White matter.
Figures
Similar articles
-
Diffusion tensor imaging in SPG11- and SPG4-linked hereditary spastic paraplegia.Int J Neurosci. 2014 Apr;124(4):261-70. doi: 10.3109/00207454.2013.836705. Epub 2013 Sep 27. Int J Neurosci. 2014. PMID: 23968121
-
White and grey matter abnormalities in patients with SPG11 mutations.J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):828-33. doi: 10.1136/jnnp-2011-300129. Epub 2012 Jun 13. J Neurol Neurosurg Psychiatry. 2012. PMID: 22696581
-
Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes.Brain. 2016 Jun;139(Pt 6):1735-46. doi: 10.1093/brain/aww068. Epub 2016 Apr 11. Brain. 2016. PMID: 27068048
-
Janus-faced spatacsin (SPG11): involvement in neurodevelopment and multisystem neurodegeneration.Brain. 2020 Aug 1;143(8):2369-2379. doi: 10.1093/brain/awaa099. Brain. 2020. PMID: 32355960 Free PMC article. Review.
-
The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.Neurosurg Focus. 2016 Sep;41(3):E12. doi: 10.3171/2016.6.FOCUS16192. Neurosurg Focus. 2016. PMID: 27581308 Review.
Cited by
-
Clinically approved immunomodulators ameliorate behavioral changes in a mouse model of hereditary spastic paraplegia type 11.Front Neurosci. 2024 Feb 16;18:1299554. doi: 10.3389/fnins.2024.1299554. eCollection 2024. Front Neurosci. 2024. PMID: 38435059 Free PMC article.
-
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients.Acta Neuropathol. 2024 Feb 2;147(1):28. doi: 10.1007/s00401-023-02675-w. Acta Neuropathol. 2024. PMID: 38305941 Free PMC article.
-
Hereditary spastic paraplegia: Novel insights into the pathogenesis and management.SAGE Open Med. 2023 Dec 29;12:20503121231221941. doi: 10.1177/20503121231221941. eCollection 2024. SAGE Open Med. 2023. PMID: 38162912 Free PMC article. Review.
-
Movement disorders in hereditary spastic paraplegias.Arq Neuropsiquiatr. 2023 Nov;81(11):1000-1007. doi: 10.1055/s-0043-1777005. Epub 2023 Nov 30. Arq Neuropsiquiatr. 2023. PMID: 38035585 Free PMC article. Review.
-
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review.Genes (Basel). 2023 Sep 3;14(9):1756. doi: 10.3390/genes14091756. Genes (Basel). 2023. PMID: 37761896 Free PMC article. Review.
References
-
- Anheim M., Lagier-Tourenne C., Stevanin G. SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J. Neurol. 2009;256:104–108. - PubMed
-
- Branco L.M., De Albuquerque M., De Andrade H.M., Bergo F.P., Nucci A., França M.C., Jr. Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. Frontotemporal Degener. 2014;15:93–97. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
